Cited 2 time in
Caspase Cleavage of Receptor Tyrosine Kinases in the Dependence Receptor Family
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Park, Gyu Hwan | - |
| dc.contributor.author | Kang, Yoo Kyung | - |
| dc.contributor.author | Paek, Seung-Mann | - |
| dc.contributor.author | Shin, Chan Young | - |
| dc.contributor.author | Han, Sun-Young | - |
| dc.date.accessioned | 2023-08-17T01:44:12Z | - |
| dc.date.available | 2023-08-17T01:44:12Z | - |
| dc.date.issued | 2023-07 | - |
| dc.identifier.issn | 1976-9148 | - |
| dc.identifier.issn | 2005-4483 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/67550 | - |
| dc.description.abstract | Dependence receptors are a group of receptor proteins with shared characteristics of transducing two different signals within cells. They can transduce a positive signal of survival and differentiation in the presence of ligands. On the other hand, dependence receptors can transduce an apoptosis signal in the absence of ligands. The function of these receptors depends on the availability of their ligands. Several receptor tyrosine kinases (RTKs) have been reported as dependence receptors. When cells undergo apoptosis by dependence receptors, the intracellular domain of some RTKs is cleaved by the caspases. Among the RTKs that belong to dependence receptors, we focused on eight RTKs (RET, HER2, MET, ALK, TrkC, EphA4, EphB3, and c-KIT) that are cleaved by caspases. In this review, we describe the features of the receptors, their cleavage sites, and the fate of the cleaved products, as well as recent implications on them being used as potential therapeutics for cancer treatment. | - |
| dc.format.extent | 11 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | 한국응용약물학회 | - |
| dc.title | Caspase Cleavage of Receptor Tyrosine Kinases in the Dependence Receptor Family | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.4062/biomolther.2022.133 | - |
| dc.identifier.scopusid | 2-s2.0-85166298707 | - |
| dc.identifier.wosid | 001032088600001 | - |
| dc.identifier.bibliographicCitation | Biomolecules & Therapeutics, v.31, no.4, pp 359 - 369 | - |
| dc.citation.title | Biomolecules & Therapeutics | - |
| dc.citation.volume | 31 | - |
| dc.citation.number | 4 | - |
| dc.citation.startPage | 359 | - |
| dc.citation.endPage | 369 | - |
| dc.type.docType | Review | - |
| dc.identifier.kciid | ART002968693 | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.subject.keywordPlus | ANAPLASTIC LYMPHOMA KINASE | - |
| dc.subject.keywordPlus | APOPTOSIS | - |
| dc.subject.keywordPlus | TRKC | - |
| dc.subject.keywordPlus | CANCERS | - |
| dc.subject.keywordPlus | LIGAND | - |
| dc.subject.keywordPlus | GROWTH | - |
| dc.subject.keywordPlus | DOMAIN | - |
| dc.subject.keywordPlus | ALPHA | - |
| dc.subject.keywordPlus | FORMS | - |
| dc.subject.keywordPlus | SITE | - |
| dc.subject.keywordAuthor | Dependence receptor | - |
| dc.subject.keywordAuthor | Cleavage | - |
| dc.subject.keywordAuthor | Receptor tyrosine kinase | - |
| dc.subject.keywordAuthor | Caspase | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
